September 24-25, 2020
9am – 4:30pm PDT
CEU certificates for Genetic Counselors will be sent by NSGC after we provide them with your final live session hours and completed survey.
If you have any questions or concerns, please contact email@example.com.
The National Society of Genetic Counselors (NSGC) has authorized Rady Children’s Institute for Genomic Medicine to offer up to 1 CEUs or 10 Category 1 contact hours for the activity RCIGM Frontiers in Pediatric Genomic Medicine Conference 2020. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Rady Children’s Hospital-San Diego Continuing Education Provider approved by the California Board of Registered Nursing, BRN Provider #00111 for ten (10.0) contact hours.
The University of California, San Diego School of Medicine designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural linguistic competency.
This activity is intended for the Genomic Community.
At the conclusion of this activity, the participants should be able to:
View the program agenda and faculty (PDF).
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.